29 Jul GPB Scientific
Tony Ward, Chief Technology Officer
GPB Scientific is a pioneering biomedical company realizing the promise of its Curate™ Cell Processing System. The Curate solution applies Deterministic Cell Separation (DCS™) technology, through a benchtop system and single-use cartridges that are currently optimized for T cells. Designed with both manufacturing and clinical potential at the forefront, Curate™ delivers the scale and performance required to advance CAR-T and TCR applications beyond their limitations today. GPB works with leading biopharma and biotech companies, cancer centers, research institutes, and universities to advance the technology within and beyond this space, with future releases targeting additional cell types, use cases, disease states, and workflow paradigms.